TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “ Company” or “PharmaTher”) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross…


Previous articlePTSF78 – Navigating the Vast Psychedelic Space: Where Do You Fit In?
Next articlePsychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant